Probiotics in Elderly Patients

Introduction to Probiotics

The American Gastroenterological Association (AGA) suggests the use of specific probiotics, including Saccharomyces boulardii and multi-strain Lactobacillus/Bifidobacterium combinations, for the prevention of C. difficile infection during antibiotic therapy in elderly patients, with low quality evidence 1, 2

The AGA recommends the following probiotics with conditional recommendation (low quality evidence):

Typical effective doses range from 10^9-10^11 CFU/day, with S. boulardii doses of approximately 10^9 CFU/day showing efficacy 4, 3
Probiotics should be taken at least 2 hours apart from antibiotic doses, and therapy should be continued for 1-2 weeks after completion of antibiotic course 1

Probiotics should be avoided in severely immunocompromised elderly patients due to the risk of fungemia (particularly with S. boulardii) 1, 3
Use with caution in elderly patients with central venous catheters, severe acute pancreatitis, or recent major gastrointestinal surgery 1
For patients who place high value on avoiding potential harms, particularly those with severe illnesses or immunosuppression, it would be reasonable to not use probiotics 1

Probiotics can be beneficial for elderly patients, particularly for prevention of C. difficile infection during antibiotic therapy and for immune enhancement, but strain selection should be based on the specific clinical indication 1
Probiotics may be most beneficial for patients at higher risk of developing CDAD (>15% baseline risk) 3
Many conditions, such as Crohn's disease, ulcerative colitis, and IBS, still lack sufficient evidence for probiotic recommendations in elderly patients 1
The use of probiotics during antibiotic therapy belongs to Class B evidence (moderate quality evidence) according to the AGA, but significant knowledge gaps exist regarding optimal strains and dosages 1, 4